Related Experiment Video
Updated: Jun 27, 2025

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
Published on: January 9, 2019
IGF2BP2 modulates autophagy and serves as a prognostic marker in glioma
Ning Li1,2, Limei Deng1,3, Yuming Zhang2
1Department of Hematology Affiliated Hospital of Guangdong Medical University Zhanjiang Guangdong China.
Abstract:
Glioma, a malignant brain tumor originating from neural glial cells, presents significant treatment challenges. However, the underlying mechanisms of glioma development are not fully understood, and effective targets are lacking. This study provides insights into the role of insulin-like growth factor 2 messenger RNA-binding protein 2 (IGF2BP2) in glioma progression and its therapeutic potential. Our analysis illustrated that elevated IGF2BP2 expression associated with significantly shorter survival among patients with low-grade glioma (LGG) in The Cancer Genome Atlas (TCGA) database. IGF2BP2 depletion led to compromised cell viability, G0/G1 phase arrest, and reduced colony-formation ability. Furthermore, ultrastructural analysis and mCherry-GFP-LC3 reporter assay revealed an increased abundance of autophagosomes upon IGF2BP2 knockdown. Western blot analysis corroborated these findings by showing reduced p62 levels coupled with increased LC3-ІІ/LC3-I ratio upon IGF2BP2 knockdown. A multicolor immunohistochemistry assay demonstrated the positive correlation between IGF2BP2 and p62 expression in glioma patient samples. Additionally, our analysis suggested a link between IGF2BP2 expression and drug-resistant markers in TCGA-LGG samples, and Cell Counting Kit-8 cell viability assay revealed that knockdown of IGF2BP2 sensitized cells to temozolomide treatment. This comprehensive exploration unveils the role of IGF2BP2 in glioma progression, shedding light on autophagy modulation and chemosensitization strategies for glioma therapy.
Insights
Insulin-like growth factor 2 messenger RNA-binding protein 2 (IGF2BP2) promotes glioma growth and resistance to chemotherapy. Reducing IGF2BP2 levels inhibits tumor cell growth and enhances sensitivity to temozolomide, offering new therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Glioma, a malignant brain tumor, lacks effective therapeutic targets due to poorly understood development mechanisms.
- Identifying novel molecular targets is crucial for improving glioma treatment outcomes.
Purpose of the Study:
- To investigate the role of insulin-like growth factor 2 messenger RNA-binding protein 2 (IGF2BP2) in glioma progression.
- To explore IGF2BP2 as a potential therapeutic target for glioma treatment.
Main Methods:
- Analysis of The Cancer Genome Atlas (TCGA) database for IGF2BP2 expression and patient survival in low-grade glioma (LGG).
- In vitro studies involving IGF2BP2 knockdown to assess effects on cell viability, cell cycle, colony formation, and autophagy (mCherry-GFP-LC3 assay, Western blot).
- Immunohistochemistry to correlate IGF2BP2 and p62 expression in patient samples; drug sensitivity assays (Cell Counting Kit-8) with temozolomide.
Main Results:
- Elevated IGF2BP2 expression correlated with shorter survival in LGG patients.
- IGF2BP2 knockdown impaired cell viability, induced G0/G1 arrest, reduced colony formation, and increased autophagy.
- IGF2BP2 knockdown reduced p62 levels and increased the LC3-II/LC3-I ratio, indicating enhanced autophagy.
- Positive correlation between IGF2BP2 and p62 expression observed in glioma samples.
- IGF2BP2 expression linked to drug resistance markers; IGF2BP2 knockdown sensitized cells to temozolomide.
Conclusions:
- IGF2BP2 plays a significant role in glioma progression by modulating autophagy.
- IGF2BP2 is associated with chemoresistance in glioma.
- Targeting IGF2BP2 presents a promising strategy for enhancing glioma chemosensitization and therapy.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
PI3K/mTOR/AKT Signaling Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
TGF - β Signaling Pathway
Abnormal Proliferation

